myirislogo
19 June, 2024 11:51 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Yes Bank 13.35 0.00
Tata Motors 137.00 41.97
Vedl 104.80 8.21
I T C 170.70 0.00
Ntpc 86.25 0.00
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
BSE:533573NSE:APLLTDBloomberg:ALPM@INReuters:ALEM.BO
Market Lot: 1Face Value: 2ISIN Demat: INE901L01018
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
05-DEC-18 Alembic Pharmaceuticals today announced that the company has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Candesartan Cilexetil Tablets USP, 4 mg, 8 mg, and 16 mg. 28-NOV-18 Alembic Pharmaceuticals announced that it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Temazepam Capsules USP 7.5mg, 15mg,...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Alembic Pharmaceuticals gets USFDA nod for Fesoterodine Fumarate Extended-Release Tablets  -IRIS 02-Feb-22
Previous

More


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2021(3)31-Mar-2021 (12)31-Mar-2020 (12)
Net sales 12696.9150514.4041325.52
Other Income17.3997.301347.54
Total Income12714.3050611.7042673.06
Cost of goods sold-10382.38-36445.80-30905.14
OPBDIT23096.6887057.5073578.20
PAT1926.9411753.909694.05
Gross Block---
Equity capital-0.000.00
EPS (Rs.)-0.000.00
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NANA
Debt / Equity (x)---
Operating margin (% of OI)181.7172.0172.4
Net margin (% of OI)15.223.222.7
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Alembic Road
Vadodara
Gujarat-390 003
PHONE
(0265) 2280 550/ 880
FAX
(0265) 2282 506
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
� All rights reserved. IRIS Business Services Limited
Disclaimer